U.S. Antimony (UAMY) director Blaise Aguirre awarded RSUs and 12,259-share option

Q: What insider activity did UAMY director Blaise Aguirre report on this Form 4?

Director Blaise A. Aguirre reported the vesting of 6,635 shares of common stock from a restricted stock unit award and the grant of a stock option for 12,259 shares , both dated January 15, 2026 .

Q: How many United States Antimony (UAMY) shares does Blaise Aguirre own after this transaction?

Following the 6,635-share RSU vesting on January 15, 2026 , Blaise A. Aguirre beneficially owned 496,001 shares of UAMY common stock directly.

Q: What are the vesting terms of Blaise Aguirre’s RSU award at UAMY?

The RSU award covers 19,903 shares of common stock. One-third (6,635 shares) vested on January 15, 2026 , and additional one-third portions are scheduled to vest on January 15, 2027 and January 18, 2028 , subject to his continued service.

Q: What are the key terms of Blaise Aguirre’s new stock option from United States Antimony?

The stock option covers 12,259 shares of UAMY common stock with an exercise price of $8.29 per share. It vests in three equal tranches of 4,087 shares on January 15, 2027, January 18, 2028, and January 16, 2029, subject to continued service.

Q: Did Blaise Aguirre pay cash for the 6,635 UAMY shares he acquired on January 15, 2026?

No. The 6,635 shares of common stock were acquired at a reported price of $0 per share as a vesting event from a time-based RSU award, rather than an open-market purchase.

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

United States Antimony Corp. director Blaise A. Aguirre reported new equity awards under the company’s Amended & Restated 2023 Equity Incentive Plan. On January 15, 2026, he acquired 6,635 shares of common stock at $0 as the first vesting tranche of a 19,903-share time-based restricted stock unit award. After this vesting, he beneficially owned 496,001 common shares directly.

On the same date, he was also granted a stock option for 12,259 shares with an exercise price of $8.29 per share. This option vests in three equal installments of 4,087 shares each on January 15, 2027, January 18, 2028, and January 16, 2029, subject to his continued service. These awards align his compensation more closely with the future performance of United States Antimony Corp.

Insider Trade Summary

2 transactions reported

Mixed 2 txns

Insider Aguirre Blaise A.

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Stock Option	12,259	$0.00	--
Grant/Award	Common Stock	6,635	$0.00	--

Holdings After Transaction: Stock Option — 0 shares (Direct); Common Stock — 496,001 shares (Direct)

Footnotes (1)

Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 6,635 shares of the 19,903 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date. Represents shares of Common Stock underlying a time-based vesting stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 4,087 shares of the 12,259 total number of shares on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through any vesting date.

Form 4 Insider Transactions: What Each Field Means →

01/23/2026 - 04:35 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Aguirre Blaise A.

(Last)

(First)

(Middle)

4438 W. LOVERS LANE, UNIT 100

(Street)

DALLAS

75209

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
UNITED STATES ANTIMONY CORP [ UAMY ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
01/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock⁽¹⁾	01/15/2026⁽¹⁾		A		6,635	A	$0	496,001	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Stock Option⁽²⁾	$8.29	01/15/2026		A		12,259⁽²⁾		⁽²⁾	⁽²⁾	Common Stock	12,259	⁽²⁾	0⁽²⁾	D

Explanation of Responses:

1. Represents shares of Common Stock underlying a time-based vesting restricted stock unit ("RSU") award granted on January 15, 2026, under the Issuer's Amended & Restated 2023 Equity Incentive Plan. One-third, or 6,635 shares of the 19,903 total number of shares of the RSU award will vest on January 15, 2026, and an additional one-third of the total number of shares will vest on January 15, 2027 and January 18, 2028, subject to the Reporting Person's continued service through each vesting date.

2. Represents shares of Common Stock underlying a time-based vesting stock option award granted on January 15, 2026 under the Issuer's Amended & Restated 2023 Equity Incentive Plan. The stock option will vest as to one-third, or 4,087 shares of the 12,259 total number of shares on January 15, 2027, and an additional one-third of the total number of shares will vest on January 18, 2028 and January 16, 2029, subject to the Reporting Person's continued service through any vesting date.

	/s/ Blaise Aguirre	01/23/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider activity did UAMY director Blaise Aguirre report on this Form 4?

Director Blaise A. Aguirre reported the vesting of 6,635 shares of common stock from a restricted stock unit award and the grant of a stock option for 12,259 shares, both dated January 15, 2026.

How many United States Antimony (UAMY) shares does Blaise Aguirre own after this transaction?

Following the 6,635-share RSU vesting on January 15, 2026, Blaise A. Aguirre beneficially owned 496,001 shares of UAMY common stock directly.

What are the vesting terms of Blaise Aguirre’s RSU award at UAMY?

The RSU award covers 19,903 shares of common stock. One-third (6,635 shares) vested on January 15, 2026, and additional one-third portions are scheduled to vest on January 15, 2027 and January 18, 2028, subject to his continued service.

What are the key terms of Blaise Aguirre’s new stock option from United States Antimony?

The stock option covers 12,259 shares of UAMY common stock with an exercise price of $8.29 per share. It vests in three equal tranches of 4,087 shares on January 15, 2027, January 18, 2028, and January 16, 2029, subject to continued service.

Under which plan were the RSU and stock option grants to UAMY’s director made?

Both the restricted stock unit award and the stock option grant to Blaise A. Aguirre were made under United States Antimony Corp.’s Amended & Restated 2023 Equity Incentive Plan.

Did Blaise Aguirre pay cash for the 6,635 UAMY shares he acquired on January 15, 2026?

No. The 6,635 shares of common stock were acquired at a reported price of $0 per share as a vesting event from a time-based RSU award, rather than an open-market purchase.